sCXCL16 as a prognostic biomarker for COVID-19 outcome

As elevated levels of the soluble CXCL16 (sCXCL16) chemokine have been reported in severe coronavirus disease 2019 (COVID-19) patients, this study examined whether sCXCL16 concentration on the first day of hospitalization predicted death in COVID-19 patients. A total of 76 patients with COVID-19 wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Boukhalfa, Yasmine, Stambouli, Nejla, Driss, Adel, Daiki, Maissa, Abouda, Amal, Razgallah, Rabie, Gharsallah, Hedi, Sellami, Walid, Abid, Rym, Hannachi, Souha, Battikh, Riadh, Benmoussa, Mohamed, Mazigh, Chakib, Ferjani, Mustapha, Elgaaied, Amel B., Labbene, Iheb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188208/
https://www.ncbi.nlm.nih.gov/pubmed/37185869
http://dx.doi.org/10.1002/jmv.28728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188208/
https://www.ncbi.nlm.nih.gov/pubmed/37185869
http://dx.doi.org/10.1002/jmv.28728

Ejemplares similares